C4 Therapeutics Inc is trading 5.2% higher at $3.77 as buying interest picks up ahead of management's participation in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026.
- Investors view these high-profile conferences as key opportunities for new institutional interest, updated strategic messaging, and potential partnering discussions.
- Such events often provide a catalyst for near-term sentiment and trading momentum within the small-cap biotechnology sector.